| Previous Close | 0.0007 |
| Open | 0.0007 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0006 - 0.0007 |
| 52 Week Range | 0.0006 - 0.0190 |
| Volume | 9,732,759 |
| Avg. Volume | 92,977,050 |
| Market Cap | 759.47k |
| Beta | 0.57 |
| PE Ratio (TTM) | -0.06 |
| EPS (TTM) | -0.01 |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.53 |
- Marketwired•2 months ago
New Edition of Textbook on Treating Canine Arthritis Includes Nutra Pharma Pain Remedy
Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter pain management market, announced today that the textbook, Multimodal Management of Canine ...
- Marketwired•3 months ago
Nutra Pharma Announcing Launch of Luxury Feet
Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter pain management market, announced today that they are expanding their product line with ...
- Marketwired•4 months ago
Nutra Pharma Featured on Univision's Spanish-Language News Show: Primer Impacto
Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter pain management market, announced today that the Company and their products were featured ...
